RxDoctor Payments Data

Justin Hohl, MD

Orthopaedic Surgery · Salt Lake City, UTNPI 1639371149

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $23,925 of the $33,921 with a category attached, or 70.5%. 19 manufacturers reported payments, led by Stryker at 43.9% of the total. Reporting peaked in 2022 at $10,177 and has fallen 69.9% since, to $3,066 in 2025.

$33,921in general payments, 2019–2025

Across 57 payments — averaging $595.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$15K
  • Kuros Biosciences USA, Inc$8K
  • Innovasis Inc$5K
  • GE HealthCare$3K
  • Reliance Medical Systems$726
  • Nexus Spine, LLC$682
  • plus $1K from 13 others

What the payments were for

  • Royalty or licence$7262%
  • Consulting fees$23,92571%
  • Travel & lodging$5,80517%
  • Food & beverage$2,7838%
  • Gifts$6822%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$33,921 in reported general payments places this provider in the 80th percentile of 221 orthopaedic surgery providers in Utah.

See all orthopaedic surgery providers in Utah

Medicare billing

Part B allowed, 2024
$149,610
Medicare patients
152
Services billed
691

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cyclobenzaprine Hcl38$234
Oxycodone Hcl30$193
Tizanidine Hcl21$123
Prednisone43$104
Tramadol Hcl15$82

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Salt Lake City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →